非处方药和膳食补充剂市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00012956
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

OTC Drug and Dietary Supplement Market Scope 2031

Buy Now

2023 年非处方药和膳食补充剂市场规模估计为 3670.1 亿美元,预计到 2031 年将达到 6801.9 亿美元;预计到 2031 年复合年增长率为 8.0%。选择非处方药治疗轻微疾病可能仍是非处方药和膳食补充剂市场的主要趋势。

非处方药和膳食补充剂市场分析

以患者为中心的护理日益受到重视、医疗技术的进步、非处方药和膳食补充剂的成本效益以及对远程医疗的日益青睐是非处方药和膳食补充剂市场增长的主要推动力。此外,老年人口的增加、家庭医疗保健的增加以及慢性病和传染病的患病率的上升也推动着非处方药和膳食补充剂市场的增长。

非处方药和膳食补充剂市场概览

非处方药 (OTC) 可供公众购买,用于一般用途。非处方药可用于治疗因疾病引起的各种症状,如咳嗽和感冒、腹泻、胃灼热、便秘、痤疮、疼痛等。另一方面,膳食补充剂可用于健身目的。这些非处方药和营养补充剂有两种类型,例如品牌或仿制。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

非处方药和膳食补充剂市场:

OTC Drug and Dietary Supplement Market: Strategic Insights

OTC Drug and Dietary Supplement Market
  • CAGR
    CAGR (2023 - 2031)
    8.0%
  • Market Size 2023
    US$ 367.01 Billion
  • Market Size 2031
    US$ 680.19 Billion

Key Players

  • GlaxoSmithKline plc
  • Sanofi
  • Johnson and Johnson Services Inc
  • Abbott
  • AbbVie Inc
  • Bausch Health Companies Inc
  • Bayer AG
  • Procter Gamble
  • Novartis AG
  • Reckitt Benckiser Group Plc

Regional Overview

Regional And Country Scope
  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

Segment 1产品(咳嗽和感冒产品、维生素和膳食补充剂、止痛药、胃肠道产品、助眠剂、口腔护理产品、眼科产品、抗酸药、女性护理、其他)
    Segment2类型(品牌、通用)
      Segment3剂型(药片、胶囊、粉剂、软膏、液体、其他)
        Segment4分销渠道(医院和零售药店、零售店、在线渠道、其他)

          非处方药和膳食补充剂市场
          • OTC Drug and Dietary Supplement Market
            复合年增长率(2023 - 2031)
            8.0%
          • 2023 年市场规模
            3670.1 亿美元
          • 2031年市场规模
            6801.9亿美元

          市场动态

          增长动力
          • 消费者对非处方药的偏好日益增加,而非处方药
          • 传染病日益流行
          未来的趋势
          • 財政部
          • 財政部
          • 財政部
          机会
          • 市场参与者开展研发活动以提供改进的非处方药

          关键人物;主力;重要一员

          • 葛兰素史克公司
          • 赛诺菲
          • 强生服务公司
          • 雅培
          • 艾伯维公司
          • 博士伦保健公司
          • 拜耳公司
          • 宝洁
          • 诺华公司
          • 利洁时集团

          区域概况

          OTC Drug and Dietary Supplement Market
          • 北美
          • 欧洲
          • 亚太
          • 南美洲和中美洲
          • 中东和非洲

          市场细分

          OTC Drug and Dietary Supplement Market产品
          • 咳嗽和感冒产品
          • 维生素和膳食补充剂
          • 止痛药
          • 胃肠产品
          • 睡眠辅助剂
          • 口腔护理产品
          • 眼科产品
          • 抗酸药
          • 女性护理
          • 其他的
          OTC Drug and Dietary Supplement Market类型
          • 品牌
          • 通用的
          OTC Drug and Dietary Supplement Market形式
          • 平板电脑
          • 胶囊
          • 粉末
          • 软膏
          • 液体
          • 其他的
          OTC Drug and Dietary Supplement Market分销渠道
          • 医院和零售药店
          • 零售店
          • 线上渠道
          • 其他的
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

          非处方药和膳食补充剂市场驱动因素和机遇

          消费者对非处方药的偏好日益增加,而非处方药

          政府和消费者对降价的压力不断加大,这将有助于加速处方药向非处方药 (Rx-to-OTC) 的转变。医生普遍支持使用非处方药治疗发烧、感冒/咳嗽和类似的小病;除此之外,医生也有一些保留意见。虽然有些仿制处方药比非处方药便宜,但大多数非处方药比处方药便宜。非处方药更受欢迎,因为它们容易获得、更实惠,而且被认为更天然。由于非处方药具有优势,人们对非处方药的偏好日益增加,这推动了非处方药和膳食补充剂市场的增长。

          市场参与者开展研发活动以提供改进的非处方药 – 非处方药和膳食补充剂市场的机遇

          消费者对非处方药品牌的信心正鼓励药品制造商对泻药、口服防腐剂、胃灼热治疗剂、戒烟产品、止痛药和营养辅助品以及其他非处方药进行越来越多的研发活动。这促使他们扩大制造和研发业务。例如,诺华消费者健康公司在印度孟买开设了第三家非处方药全球研发中心。在许多发达国家,消费者可获得的非处方药阵容正在扩大。与此同时,在新兴国家,这些药物的使用正在增加,而相关的医疗保健系统保持稳定,因此,非处方药有望增长。市场的主要市场参与者采用并购等策略来发展非处方药和膳食补充剂市场。

          非处方药和膳食补充剂市场报告细分分析

          有助于非处方药和膳食补充剂市场分析的关键部分是产品、类型、形式和分销渠道。

          • 根据产品,非处方药和膳食补充剂市场细分为咳嗽和感冒产品、维生素和膳食补充剂、止痛药、胃肠道产品、助眠剂、口腔护理产品、眼科产品、抗酸药、女性护理等。止痛药部分在 2023 年占据了最大的市场份额。
          • 根据类型,非处方药和膳食补充剂市场分为品牌药和仿制药。仿制药部分在 2023 年占据了最大的市场份额。
          • 根据形式,市场分为片剂、胶囊、粉末、软膏、液体和其他。片剂部分在 2023 年占据了最大的市场份额。
          • 在分销渠道方面,市场细分为医院和零售药店、零售店、在线渠道和其他渠道。医院和零售药店部门在 2023 年占据了最大的市场份额。

          非处方药和膳食补充剂市场份额按地区分析

          非处方药和膳食补充剂市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

          北美主导着非处方药和膳食补充剂市场。在北美,美国占据着非处方药和膳食补充剂市场的很大份额。北美的增长特点是传染病患病率高、政府对制药行业的支持不断增加、医疗支出不断增加、非处方药的采用率不断提高、远程医疗服务的采用率不断提高、服务提供商数量不断增加以及医疗机构不断发展。另一方面,美国所有年龄段的人对膳食补充剂的需求都高得多。

          非处方药和膳食补充剂市场报告范围

          报告属性细节
          2023 年的市场规模3670.1亿美元
          2031 年市场规模6801.9亿美元
          全球复合年增长率(2023 - 2031)8.0%
          历史数据2021-2022
          预测期2024-2031
          涵盖的领域按产品
          • 咳嗽和感冒产品
          • 维生素和膳食补充剂
          • 止痛药
          • 胃肠产品
          • 睡眠辅助剂
          • 口腔护理产品
          • 眼科产品
          • 抗酸药
          • 女性护理
          • 其他的
          按类型
          • 品牌
          • 通用的
          按形式
          • 平板电脑
          • 胶囊
          • 粉末
          • 软膏
          • 液体
          • 其他的
          按分销渠道
          • 医院和零售药店
          • 零售店
          • 线上渠道
          • 其他的
          覆盖地区和国家北美
          • 我们
          • 加拿大
          • 墨西哥
          欧洲
          • 英国
          • 德国
          • 法国
          • 俄罗斯
          • 意大利
          • 欧洲其他地区
          亚太
          • 中国
          • 印度
          • 日本
          • 澳大利亚
          • 亚太其他地区
          南美洲和中美洲
          • 巴西
          • 阿根廷
          • 南美洲和中美洲其他地区
          中东和非洲
          • 南非
          • 沙特阿拉伯
          • 阿联酋
          • 中东和非洲其他地区
          市场领导者和主要公司简介
          • 葛兰素史克公司
          • 赛诺菲
          • 强生服务公司
          • 雅培
          • 艾伯维公司
          • 博士伦保健公司
          • 拜耳公司
          • 宝洁
          • 诺华公司
          • 利洁时集团
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

          非处方药和膳食补充剂市场新闻和最新发展

          通过收集一级和二级研究后的定性和定量数据来评估非处方药和膳食补充剂市场,其中包括重要的公司出版物、协会数据和数据库。以下是病毒抗原和策略市场发展的列表:

          • Emcure Pharmaceuticals 宣布其产品 Galact 进军非处方 (OTC) 市场。Galact 富含 Shatavari 和其他六种草药的功效,经过精心配制,可提高母亲的母乳产量。(来源:Nuffoods Spectrum,新闻稿,2024 年)
          • McKesson 推出了其自有品牌 Foster & Thrive 系列非处方 (OTC) 健康和保健产品。据该公司称,新品牌将统一 McKesson 的自有品牌组合,其中包括以 Health Mart 和 Sunmark 品牌销售的非处方产品。(来源:Bareback Media Pvt. Ltd,新闻稿,2023 年)

          非处方药和膳食补充剂市场报告覆盖范围和交付成果

          “非处方药和膳食补充剂市场规模和预测(2021-2031 年)”报告对市场进行了详细分析,涵盖以下领域:

          • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
          • 市场动态,如驱动因素、限制因素和关键机遇
          • 未来主要趋势
          • 详细的 PEST/波特五力分析和 SWOT 分析
          • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
          • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
          • 详细的公司简介

          OTC Drug and Dietary Supplement Market Report Scope

          Report Attribute Details
          Market size in US$ 367.01 Billion
          Market Size by US$ 680.19 Billion
          Global CAGR 8.0%
          Historical Data 2021-2022
          Forecast period 2024-2031
          Segments Covered By 产品(咳嗽和感冒产品、维生素和膳食补充剂、止痛药、胃肠道产品、助眠剂、口腔护理产品、眼科产品、抗酸药、女性护理、其他)
          By 类型(品牌、通用)
          By 剂型(药片、胶囊、粉剂、软膏、液体、其他)
          By 分销渠道(医院和零售药店、零售店、在线渠道、其他)
          Regions and Countries Covered 北美(美国、加拿大、墨西哥)
          • 北美(美国、加拿大、墨西哥)
          欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          Market leaders and key company profiles
        • GlaxoSmithKline plc
        • Sanofi
        • Johnson and Johnson Services Inc
        • Abbott
        • AbbVie Inc
        • Bausch Health Companies Inc
        • Bayer AG
        • Procter Gamble
        • Novartis AG
        • Reckitt Benckiser Group Plc
        • Report Coverage
          Report Coverage

          Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

          Segment Covered
          Segment Covered

          This text is related
          to segments covered.

          Regional Scope
          Regional Scope

          North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

          Country Scope
          Country Scope

          This text is related
          to country scope.

          The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

          1. Data Collection and Secondary Research:

          As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

          Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

          1. Primary Research:

          The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

          For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

          A typical research interview fulfils the following functions:

          • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
          • Validates and strengthens in-house secondary research findings
          • Develops the analysis team’s expertise and market understanding

          Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

          • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
          • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

          Below is the breakup of our primary respondents by company, designation, and region:

          Research Methodology

          Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

          1. Data Analysis:

          Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

          • Macro-Economic Factor Analysis:

          We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

          • Country Level Data:

          Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

          • Company Profile:

          The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

          • Developing Base Number:

          Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

          1. Data Triangulation and Final Review:

          The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

          We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

          We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

          Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

          Trends and growth analysis reports related to Pharmaceuticals : READ MORE..